Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/8/2020
SIETES contiene 93082 citas

 
 
 1 a 20 de 20258 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Parsons L. Novavax reports promising phase 1 results for coronavirus vaccine. PMLiVE 2020:5 de agosto. [Ref.ID 103702]
2. Cita con resumen
Parsons L. Roche’s Actemra fails in late-stage severe COVID-19 study. PMLiVE 2020:29 de julio. [Ref.ID 103699]
3. Cita con resumen
Parsons L. Moderna’s COVID-19 vaccine enters pivotal phase 3 trial. PMLiVE 2020:28 de julio. [Ref.ID 103698]
4. Cita con resumen
Novoa A. Ni formación ni investigación: relaciones públicas, propaganda y corrupción. NoGracias 2020:2 de agosto. [Ref.ID 103695]
5. Cita con resumen
Ikematsu H, Hayden FG, Kawaguchi K, Kinoshita M, de Jong MD, Lee N, Takashima S, Noshi T, Tsuchiya K, Uehara T. Baloxavir marboxil for prophylaxis against influenza in household contacts. N Engl J Med 2020:23 de julio. [Ref.ID 103693]
8. Cita con resumen
Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, et al.. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet 2020:20 de julio. [Ref.ID 103690]
9. Cita con resumen
The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with covid-19 — Preliminary report. N Engl J Med 2020:17 de julio. [Ref.ID 103689]
10.Enlace a cita original Cita con resumen
Skipper CP, Pastick KA, Engen NW, Bangdiwala AS, Abassi M, Lofgren SM, Williams DA, Okafor EC, Pullen MF, Nicol MR, Nascene AA, Hulisiek KH, Cheng MP, Luke D, Lother SA, MacKenzie LJ, Drobot G, Kelly LE, Schwartz IS, Zarychanski R, McDonald EG, Lee TC, Rajasingham R, Boulware DR. Hydroxychloroquine in nonhospitalized adults with early COVID-19. A randomized trial. Ann Intern Med 2020:16 de julio. [Ref.ID 103687]
11. Cita con resumen
Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough P, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, et al. for the mRNA-1273 Study Group. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report. N Engl J Med 2020:14 de julio. [Ref.ID 103684]
12.Enlace a cita originalTiene citas relacionadas Cita con resumen
Moynihan R, MacDonald H, Bero L, Godlee F. Commercial influence and covid-19. BMJ 2020;369:24 de junio. [Ref.ID 103680]
13. Cita con resumen
14. Cita con resumen
Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, et al.. Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019. The GRECCO-19 randomized clinical trial. JAMA Network Open 2020;3:24 de junio. [Ref.ID 103674]
15. Cita con resumen
Addis A, Ganazzani A, Trotta MP, Magrini N, for the Italian Medicines Agency Scientific Committee and COVID-19 Crisis Unit. Promoting better clinical trials and drug information as public health interventions for the COVID-19 emergency in Italy. Ann Intern Med 2020:16 de junio. [Ref.ID 103673]
16. Cita con resumen
Taylor P. Gilead will test inhaled remdesivir in earlier-stage COVID-19. PMLiVE 2020:23 de junio. [Ref.ID 103672]
17.Enlace a cita original Cita con resumen
Samper E. Así afectan las prisas a la ciencia que rodea al coronavirus . eldiario.es 2020:23 de junio. [Ref.ID 103667]
19. Cita con resumen
Hart LA, Phelan EA, Yi JY, Marcum ZA, Gray SL. Use of fall eisk-increasing drugs around a fall-related injury in older adults: a systematic review. J Am Geriatr Soc 2020;68:junio. [Ref.ID 103662]
20. Cita con resumen
Mullard A. COVID-19 vaccine development pipeline gears up. Lancet 2020:6 de junio. [Ref.ID 103658]
Seleccionar todas
 
 1 a 20 de 20258 siguiente >>